Papillary craniopharyngioma management in the era of BRAF and MEK inhibition
Utilizing surgery and BRAF/MEKi without adjuvant radiation, we demonstrate excellent disease control with reversible toxicity. Avoiding additional treatments may spare vital functions and unnecessary procedures.
Authors
- Pierre Giglio (ORCID: https://orcid.org/0000-0001-5165-0984)
- Daniel Kreatsoulas (ORCID: https://orcid.org/0000-0002-9727-7019)
- Santino Cua (ORCID: https://orcid.org/0000-0002-0776-157X)
- Luma Ghalib (ORCID: https://orcid.org/0000-0003-0077-0665)
- Daniel M. Prevedello (ORCID: https://orcid.org/0000-0003-0214-2339)
- Mark Damante (ORCID: https://orcid.org/0000-0001-9750-6283)
- Kyle C. Wu
Institutions
- The Ohio State University Wexner Medical Center (US)
- Neurological Surgery (US)
Publication Details
- Journal
- Journal of Neuro-Oncology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1007/s11060-025-04969-3
- Citations
- 4
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.18